American Academy of Pediatrics

It is increasingly clear that there is little scientific basis for administering puberty blockers to gender-dysphoric youth. Consequently, many European countries have now effectively banned their use outside of official studies. Now, the New Zealand Ministry of Health has similarly found that there is a “dearth” of evidence supporting blocking normal adolescence in youngsters who feel that their gender is different from their sex. The New Zealand study reviewed all the literature on the question published before September 30, 2023. In other words, it was a study of the findings of published studies. First, it found that studies claiming that puberty blockers helped ease depression were of very poor quality. From “Impact of Puberty Blockers in Gender-Dysphoric Adolescents” (my emphasis): Impact of puberty blockers on Read More ›